JACoW is a publisher in Geneva, Switzerland that publishes the proceedings of accelerator conferences held around the world by an international collaboration of editors.
TY - CONF AU - Mandrillon, J. AU - Abs, M. AU - Cailliau, P. AU - Cosson, O. AU - Deprez, S. AU - Donzel, X. AU - Goosse, G. AU - Jongen, Y. AU - Kleeven, W.J.G.M. AU - Koffel, L.C.L. AU - Maunoury, L. AU - Nuttens, V. AU - Otu, Y. AU - Paradis, Y. AU - Velten, Ph. ED - Zhang, Tianjue ED - Schaa, Volker R.W. ED - An, Shizhong ED - Kiselev, Daniela ED - Liu, Yuntao ED - Li, Pengzhan TI - Status on NHa C400 Cyclotron for Hadrontherapy J2 - Proc. of CYCLOTRONS2022, Beijing, China, 05-09 December 2022 CY - Beijing, China T2 - International Conference on Cyclotrons and their Applications T3 - 23 LA - english AB - C400 is an isochronous cyclotron for cancer therapy delivering high dose rates of alphas to carbons at 400 MeV/amu extracted by electrostatic deflector and protons at 260 MeV extracted by stripping of molecular hydrogen. IBA started to pre-design the system more than 13 years ago in collaboration with JINR. The responsibility for the development of C400 has meanwhile been taken over by the French company Normandy Hadontherapy (NHa). However, the study and design work continued with a very strong involvement of IBA for the past 3 years, from concept on paper to reality. We will describe the most innovative concepts and technical solutions on the accelerator from source to extraction and show the construction progress. PB - JACoW Publishing CP - Geneva, Switzerland SP - 264 EP - 268 KW - cyclotron KW - extraction KW - proton KW - resonance KW - hadron DA - 2023/10 PY - 2023 SN - 2673-5482 SN - 978-3-95450-212-7 DO - doi:10.18429/JACoW-CYCLOTRONS2022-THBI01 UR - https://jacow.org/cyclotrons2022/papers/thbi01.pdf ER -